| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
Department of Geriatrics, Endocrinology and Metabolism (N.A., T.A., Y.S., K.H.), Shinshu University School of Medicine, Matsumoto, Nagano-ken, Japan, and Department of Pharmacology (T.S., M.K., G.W.G.S.), College of Veterinary Medicine, Cornell University, Ithaca, New York 14853-6401
Address all correspondence and requests for reprints to: Toru Aizawa, M.D., Department of Geriatrics, Endocrinology and Metabolism, Shinshu University School of Medicine, 31-1 Asahi, Matsumoto, Nagano-ken, Japan 390.
In the rat pancreatic ß cell, low concentrations of glucose potentiate D-glyceraldehyde (GA)-induced insulin release without any potentiation of the triose-induced elevation of cytosolic free Ca2+ concentration. Namely, 23 mM glucose strongly potentiates 5 mM GA-induced insulin release, and the combination of stimulatory concentration of glucose (10 mM) and 5 mM GA elicits far more than additive insulin release: this glucose action is independent of ATP-sensitive K+ channel closure because it can be seen in the presence of diazoxide, an opener of the K+ channel. The triose-induced elevation of cytosolic free Ca2+ concentration was not potentiated by the presence of 3 mM glucose, and oxidation of labeled GA by the islet cells was not enhanced by the presence of glucose. The glucose action can be mimicked by mannose, but not by galactose, and was suppressed by inhibition of glucose phosphorylation with mannoheptulose or 2-deoxyglucose. Glucose also potentiates 2-ketoisocaproate-induced insulin release. In contrast, a combination of GA and 2-ketoisocaproate elicits only additive insulin release. Strikingly, 3 mM glucose does not potentiate insulin release in response to a depolarizing concentration of K+. Therefore, at least two signal pathways, one from upper glycolytic flux and one from mitochondrial metabolism, must converge to provide the potentiation of insulin release. We conclude that the upper glycolytic flux, acting at a site unrelated to the elevation of cytosolic free Ca2+, potentiates insulin release triggered by triose and mitochondrial fuels.
This article has been cited by other articles:
![]() |
M. Fukaya, A. Mizuno, H. Arai, K. Muto, T. Uebanso, K. Matsuo, H. Yamamoto, Y. Taketani, T. Doi, and E. Takeda Mechanism of rapid-phase insulin response to elevation of portal glucose concentration Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E515 - E522. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Huang, S. Bu, Y. Yu, Z. Guo, G. Ghatnekar, M. Bu, L. Yang, B. Lu, Z. Feng, S. Liu, et al. Diazoxide Prevents Diabetes through Inhibiting Pancreatic {beta}-Cells from Apoptosis via Bcl-2/Bax Rate and p38-{beta} Mitogen-Activated Protein Kinase Endocrinology, January 1, 2007; 148(1): 81 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Juntti-Berggren, D.-L. Webb, P. O.G. Arkhammar, V. Schultz, E. K. H. Schweda, K. Tornheim, and P.-O. Berggren Dihydroxyacetone-induced Oscillations in Cytoplasmic Free Ca2+ and the ATP/ADP Ratio in Pancreatic {beta}-Cells at Substimulatory Glucose J. Biol. Chem., October 17, 2003; 278(42): 40710 - 40716. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chen, Z. Yang, R. Wu, and J. L. Nadler Lisofylline, a Novel Antiinflammatory Agent, Protects Pancreatic {beta}-Cells from Proinflammatory Cytokine Damage by Promoting Mitochondrial Metabolism Endocrinology, June 1, 2002; 143(6): 2341 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Miwa, N. Ichimura, M. Sugiura, Y. Hamada, and S. Taniguchi Inhibition of Glucose-Induced Insulin Secretion by 4-Hydroxy-2-Nonenal and Other Lipid Peroxidation Products Endocrinology, August 1, 2000; 141(8): 2767 - 2772. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |